Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04258514

The Effect of Virtual Reality on Anxiety During Vasectomy

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Nebraska · Academic / Other
Sex
Male
Age
19 Years – 100 Years
Healthy volunteers
Accepted

Summary

The primary purpose of the study is to determine if the use of Virtual Reality (VR) goggles reduces the degree of anxiety patients experience during vasectomy procedures. The eligibility criteria include a.) appropriate age (19-100 years); b.) undergoing elective vasectomy procedure for purpose of desired sterility; c.) acceptance of wearing goggles; d) able to provide informed consent.There will be two groups, Group A will wear VR goggles and Group B will not. Evaluations will be done by survey to include questions regarding the level of anxiety experienced during the procedure, along with satisfaction scores of the experience.

Detailed description

1. The aim of the study is to evaluate the efficacy of virtual reality goggles (VRG) for improving the patient's experience during vasectomy procedure. 2. The secondary aim is to determine if VRG reduces the level of anxiety experienced during vasectomy procedure. VR is an immersive, multisensory experience in a three-dimensional environment designed to replicate a real world. It has been shown in multiple studies to decrease acute and chronic pain in a variety of clinical settings. The mechanism is due to distraction by activating visual, auditory and proprioceptive senses. One example of this is a report by G. Pooja et. al. where in VR goggles reduced pain and medication use during orthopedic procedures (1). Another study found decrease in pain in medically treated patients (n=50 patients in 2 groups) after a 15 minute VR viewing on pain reduction compared to 2 -D viewing (2).

Conditions

Interventions

TypeNameDescription
PROCEDUREVirtual Reality during vasectomyVirtual Reality
PROCEDUREStandard VasectomyNo Virtual Reality

Timeline

Start date
2021-04-01
Primary completion
2021-06-23
Completion
2021-06-23
First posted
2020-02-06
Last updated
2023-08-15

Source: ClinicalTrials.gov record NCT04258514. Inclusion in this directory is not an endorsement.